Kevin MoranSenior Vice President, Chief Financial Officer and Treasurer at Vanda PharmaceuticalsExecutive
CorporateVanda Pharma's NEREUS Becomes First New Motion Sickness Drug in 40 Years — Shares Surge 18%Dec 31, 2025